N/A
N=37
Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metabolites in Healthy Women
Skin Diseases
Bottom Line
View on ClinicalTrials.gov: NCT00541931 ↗Enrolled (actual)
37
Serious AEs
0.0%
Results posted
Nov 2017
Primary outcome: Primary: Fold Change in Long Chain Fatty Acids — 1; 0.76 Fold Change in long chain fatty acids
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Dietary Supplement: LifePak Nano (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Stanford University
- Primary completion
- Mar 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Fold Change in Long Chain Fatty Acids |
1; 0.76 | — |
| PRIMARY Change in Fine Wrinkling |
0.24; -1.77 | — |
Summary
We are seeking healthy female volunteers to determine if multinutrient supplementation affects visible signs of skin aging as well as blood measurements of aging. We are seeking smokers and non-smokers.
Eligibility Criteria
Inclusion Criteria:- Fitzpatrick Skin type I or II
- Nonpregnant Females, age 18-30 or 50-70
- Body Mass Index Normal or Overweight
- If age 18-30, must be non-smoker
- Willing to fast for 8 hours prior to a blood draw; Exclusion Criteria:- History of cosmetic surgery
- Use of anti-aging medications within 3 months of enrollment
- Use of over-the-counter anti-aging creams (not sunscreens) more than once per week within one month of enrollment
- Use of dietary supplements including vitamins within one month of enrollment
- Use of tanning beds or excessive UV exposure (greater than 2 hours per day) within one month of enrollment
- Use of sunless tanners within one month of enrollment
- Uncontrolled or ongoing serious medical condition
- Participation in another clinical study involving use of an investigational drug or product
- Medical condition which, at the discretion of the investigator, will have a significant impact on ability to judge participant's skin characteristics, including age.
Data sourced from ClinicalTrials.gov (NCT00541931). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.